|
KR20190024441A
|
|
Composition comprising polydeoxyribonucleotide for treating Complex Regional Pain Syndrome
|
|
KR20190003247A
|
|
Combined composition for preventing, alleviating or treating premenstrual syndrome and menstrual pain
|
|
CN108289825A
|
|
Injection hyaluronic acid compositions containing derivatives of hyaluronic acids and DNA fragmentation and its application
|
|
KR20180027126A
|
|
Hemostatic Composition comprising cross-linked hyaluronic acid derivative matrix
|
|
KR20170073388A
|
|
Composition for treating osteoarthritis comprising hydrophilized sulfasalazine and hyaluronic acid and method for preparing the same
|
|
KR20140058721A
|
|
Purification method of hyaluronidase
|
|
KR20140057824A
|
|
Stabilizer for hyaluronidase and liquid formulation comprising hyaluronidase
|
|
KR20130066319A
|
|
Composition for inhibit after-cataract and preparation method of the same
|
|
KR20130000988A
|
|
High-degree purification method of hyaluronidases and parenteral-injection using there
|
|
KR20110106005A
|
|
Pharmaceutical preparation of sustained-release formular for treatment of musculoskeletal inflammatory
|
|
KR20110012638A
|
|
Pharmaceutical formulation for increasing the secretion of bile and improvement of declined liver function by liver-disease
|
|
KR20090103209A
|
|
Human Interleukin-2 Isoforms
|
|
KR20090095927A
|
|
Production method of host microorganism having high yield productivity of recombinant human active protein
|
|
KR20020089083A
|
|
Cell culture media
|
|
KR20020082257A
|
|
Automatic cell freezer and freezing method using thereof
|
|
KR20010099550A
|
|
Cell culture media
|
